SCHIZOPHRENIA SPECTRUM DISORDERS
Clinical trials for SCHIZOPHRENIA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug help schizophrenia patients lose weight?
Disease control OngoingThis study tests whether semaglutide, a drug used for diabetes and weight loss, can help people with schizophrenia who are overweight or obese and did not lose weight on metformin. About 92 participants will receive either semaglutide or a placebo. The main goal is to see if sema…
Matched conditions: SCHIZOPHRENIA SPECTRUM DISORDERS
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Writing your way to wellness: new study tests creative writing for mental health
Symptom relief OngoingThis study tests a 15-session creative writing program called REWRITALIZE for people with serious mental illnesses like schizophrenia, bipolar disorder, or severe depression. About 300 adults will either join the writing groups plus their usual care, or stay on a waiting list wit…
Matched conditions: SCHIZOPHRENIA SPECTRUM DISORDERS
Phase: NA • Sponsor: Amager Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC